Cryptotanshinone Alleviates Cardiac Hypertrophy Through SIRT3-Mediated Epigenetic Regulation and Mitochondrial Dynamics
Open Access
- 15 October 2026
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 15 (10) , 1329
Abstract
Cryptotanshinone (CTS), a bioactive diterpenoid extracted from Salvia miltiorrhiza Bunge, has long been recognized as a traditional Chinese herbal compound. This study reveals that CTS exerts potent anti-hypertrophic effects against angiotensin II (Ang II)-induced cardiac hypertrophy by targeting Sirtuin 3 (SIRT3)-mediated epigenetic and mitochondrial pathways. In both in vitro and in vivo models, CTS ameliorated pathological hypertrophy, oxidative stress, inflammation, and apoptosis. Mechanistically, CTS upregulated SIRT3, reducing histone H3K9 acetylation (H3K9ac) and restoring mitochondrial dynamics by balancing fission (DRP1) and fusion (MFN2) proteins. Genetic ablation of SIRT3 exacerbated hypertrophy and mitochondrial dysfunction, while pharmacological inhibition with 3-TYP abolished CTS benefits. These findings elucidate CTS as a therapeutic candidate for cardiac hypertrophy by activating SIRT3, which is accompanied by reduced H3K9ac and restored DRP1/MFN2 balance, highlighting potential in cardiac hypertrophy treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82003985)
- Natural Science Foundation of Jilin Province (YDZJ202401082ZYTS)
- China Postdoctoral Science Foundation (2020T130568)
This publication has 37 references indexed in Scilit:
- Therapeutic potential of phytochemical compounds in cardiovascular disease: a comprehensive reviewSaudi Pharmaceutical Journal, 2026
- Cryptotanshinone: an Encouraging Natural Compound for Treating Metabolic DiseasesCurrent Pharmacology Reports, 2026
- Versatile DNA Hydrogel‐Mediated Delivery of Ginsenoside‐Encapsulated Small Extracellular Vesicles to Boost Diabetic Wound RepairAdvanced Science, 2026
- Cryptotanshinone alleviates immunosuppression in endometriosis by targeting MDSCs through JAK2/STAT3 pathwayPhytomedicine, 2024
- Sentrin-specific protease 1 maintains mitochondrial homeostasis through targeting the deSUMOylation of sirtuin-3 to alleviate oxidative damage induced by hepatic ischemia/reperfusionFree Radical Biology and Medicine, 2023
- Mitochondria and NLRP3 inflammasome in cardiac hypertrophyMolecular and Cellular Biochemistry, 2023
- Paeoniflorin alleviates AngII-induced cardiac hypertrophy in H9c2 cells by regulating oxidative stress and Nrf2 signaling pathwayBiomedicine & Pharmacotherapy, 2023
- Mitochondrial proteins in heart failure: The role of deacetylation by SIRT3Pharmacological Research, 2021
- Oxidative stress in cardiac hypertrophy: From molecular mechanisms to novel therapeutic targetsFree Radical Biology and Medicine, 2021
- Human sirtuin 3 (SIRT3) deacetylates histone H3 lysine 56 to promote nonhomologous end joining repairDNA Repair, 2018